Financials
Financial year 2025
Gross margin
€ 1.8 million
▲ 10% vs 2024
Profit
Healthy€ 218,895
▼ 14% vs 2024
Debts
Low€ 834,344
▲ 10% vs 2024
SERVIER R & D BENELUX from Anderlecht, company number BE0433543775, closed financial year 2025 with a result of € 218,895 after tax. For that financial year SERVIER R & D BENELUX recorded a gross margin of € 1.8 million and equity of € 5.4 million. Compared with financial year 2024, the result moved from € 254,387 to € 218,895. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 10, 2026.
What happened at SERVIER R & D BENELUX?
What happened at SERVIER R & D BENELUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 218,895 (▼ 14% vs 2024). Source: NBB ↗
- Philippe Gonnard stepped down as director. NBB
- Claude Bertrand stepped down as director. NBB
- Philippe Gonnard became a director. NBB
- Claude Bertrand became a director. NBB
- New establishment in Anderlecht. KBO
- Start of the company according to the CBE. KBO
In short
From € 113,037 profit in 2022 to € 218,895 profit in 2025.
Paid € 324,708 in corporate taxes since 2022.
Best year ever: 2024, with € 254,387 profit.
On average € 274,400 of value added per employee in 2025.
A new publication or filing at SERVIER R & D BENELUX? We notify you, reason included.
Follow SERVIER R & D BENELUXNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by Institut Servier de Medecine Translationnelle, SARL (100%) and Institut Servier d'Innovation Therapeutique, SARL (0.1%).
Directors
According to the 2025 annual accounts
since 2025 · until 2026
Claude Bertrand
Managing director
since 2025 · until 2026
Shareholders
Institut Servier de Medecine Translationnelle, SARL
100%
Institut Servier d'Innovation Therapeutique, SARL
0.1%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Bergense Steenweg 1424
1070 Anderlecht
Internationalelaan 57
1070 Anderlecht
Active since 24 March 1988
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 12 companies are registered at this address.
HILTI BELGIUM
€ 99.8 million revenue · 2024
Servier Benelux
€ 89.1 million revenue · 2025
Euthérapie Benelux same network
€ 4.7 million gross margin · 2025
MANUTAN
€ 59.3 million revenue · 2025
DAXISPHARMA
€ 7.1 million gross margin · 2025
+7 more
Details
- Company number
- 0433.543.775
- VAT number
- BE 0433.543.775
- Registered office
- Bergense Steenweg 1424, 1070 Anderlecht
- Names & denominations
- SERVIER R & D BENELUX
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 15 March 1988
- Peppol
- Active · Active since 16 Jan 2026
- Activities · NACE
Technische testen en analyses
Overige technische testen en toetsen
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied